BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15964528)

  • 1. [Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Azzabi O; Nefzi L; Ben Hariz M; Ben Mrad N; Ben Ammar B; Maherzi A
    Arch Pediatr; 2005 Jul; 12(7):1120-3. PubMed ID: 15964528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recovery of Cushing syndrome revealing McCune-Albright syndrome].
    Halioui-Louhaichi S; Dridi Y; Azzabi O; Selmi I; Fetni I; Siala N; Maherzi A
    Arch Pediatr; 2016 Jan; 23(1):61-5. PubMed ID: 26552628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome.
    Gillis D; Rösler A; Hannon TS; Koplewitz BZ; Hirsch HJ
    J Pediatr; 2008 Jun; 152(6):882-4, 884.e1-4. PubMed ID: 18492536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal McCune-Albright syndrome with systemic involvement: a case report.
    Lourenço R; Dias P; Gouveia R; Sousa AB; Oliveira G
    J Med Case Rep; 2015 Sep; 9():189. PubMed ID: 26341786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
    Vong CH; Forest M; Nicolino M
    J Pediatr; 2009 Mar; 154(3):467-8; author reply 468-9. PubMed ID: 19874777
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome.
    Kirk JM; Brain CE; Carson DJ; Hyde JC; Grant DB
    J Pediatr; 1999 Jun; 134(6):789-92. PubMed ID: 10356155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Quarters Adrenalectomy for Infantile-Onset Cushing Syndrome due to Bilateral Adrenal Hyperplasia in McCune-Albright Syndrome.
    Itonaga T; Goto H; Toujigamori M; Ohno Y; Korematsu S; Izumi T; Narumi S; Hasegawa T; Ihara K
    Horm Res Paediatr; 2017; 88(3-4):285-290. PubMed ID: 28528327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Cushing's syndrome: an unusual presentation of McCune-Albright syndrome in the neonatal period.
    Paris F; Philibert P; Lumbroso S; Servant N; Kalfa N; Sultan C
    Horm Res; 2009; 72(5):315-9. PubMed ID: 19844118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing syndrome as a failed cardiac screen in a patient with McCune-Albright syndrome: a case report.
    Foster C; Al Zubeidi H; Diaz-Thomas A
    J Med Case Rep; 2022 Sep; 16(1):342. PubMed ID: 36109759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia.
    Boston BA; Mandel S; LaFranchi S; Bliziotes M
    J Clin Endocrinol Metab; 1994 Sep; 79(3):890-3. PubMed ID: 8077378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH-independent Cushing's syndrome due to ectopic endocrinologically functional adrenal tissue caused by a
    Takedani K; Yamamoto M; Tanaka S; Ishihara S; Taketani T; Kanasaki K
    Front Endocrinol (Lausanne); 2022; 13():934748. PubMed ID: 35966069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metyrapone for Cushing's syndrome.
    Inagaki M; Akizuki N; Kugaya A; Fujii H; Akechi T; Uchitomi Y
    Am J Psychiatry; 2002 Jul; 159(7):1246. PubMed ID: 12091216
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cushing's syndrome: special issues].
    Goñi Iriarte MJ
    Endocrinol Nutr; 2009 May; 56(5):251-61. PubMed ID: 19627746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment for Cushing's syndrome].
    Nishikawa T; Saito J; Omura M
    Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of diabetes mellitus in Cushing's syndrome.
    Munir A; Newell-Price J
    Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Severe McCune-Albright syndrome presenting with neonatal Cushing syndrome: navigating through clinical obstacles.
    Unsal Y; Gozmen O; User İR; Hızarcıoglu H; Gulhan B; Ekinci S; Karagoz T; Ozon ZA; Gonc EN
    Front Endocrinol (Lausanne); 2023; 14():1209189. PubMed ID: 37560302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple neonatal endocrinopathies in McCune-Albright syndrome.
    Bareille P; Azcona C; Stanhope R
    J Paediatr Child Health; 1999 Jun; 35(3):315-8. PubMed ID: 10404460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The medical management of Cushing's syndrome during pregnancy.
    Lim WH; Torpy DJ; Jeffries WS
    Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):1-6. PubMed ID: 23305861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.